Propofol inhibited glioma cell proliferation, migration, and invasion by regulating the miR-410-3p/transforming growth factor-B receptor type 2 (TGFBR2) axis, the miR-206/Rho-associated protein kinase 1 (ROCK1) axis, and miR-134 expression, as well as suppressing the PI3K/Akt signaling pathway [370,371,372]. Here, TGFBR2 is linked to central nervous system cancer.